Clene (CLNN) Retained Earnings (2019 - 2026)
Clene (CLNN) posted Retained Earnings of -$329.8 million for Q2 2026, down 6.98% on a QoQ basis from -$308.3 million in Q4 2025, and down 13.61% year-over-year from -$381.8 million in Q2 2025.
Analysis
Clene (CLNN) Retained Earnings (2019 - 2026) Analysis & Trends
Clene has reported Retained Earnings for 8 years, with the latest figure at -$329.8 million in Q2 2026.
- On a quarterly basis, Retained Earnings fell 13.61% year-over-year to -$329.8 million in Q2 2026; TTM through Jun 2026 was -$329.8 million, a 13.61% decrease from a year earlier, with the FY2025 full-year figure at -$308.3 million, down 9.28% from the prior year.
- Retained Earnings was -$329.8 million for Q2 2026 at Clene, down from -$308.3 million in the prior quarter.
- The five-year high for Retained Earnings was $257.9 million in Q1 2024, with the low at -$329.8 million in Q2 2026.
- Average Retained Earnings over 5 years is -$88.6 million, with a median of -$205.0 million recorded in 2023.
- The largest YoY upside for Retained Earnings was 238.78% in 2023 against a maximum downside of 214.89% in 2023.
- Over 5 years, Retained Earnings stood at $196.2 million in 2022, then jumped by 30.4% to $255.9 million in 2023, then slumped by 210.24% to -$282.1 million in 2024, then decreased by 9.28% to -$308.3 million in 2025, then fell by 6.98% to -$329.8 million in 2026.
- The last three Retained Earnings figures came in at -$329.8 million (Q2 2026), -$308.3 million (Q4 2025), and -$299.1 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 112.09 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | -4.00 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 1.10 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 9.16 Bn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | -329.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -329.81 Mn |
| Dec 31, 2025 | -308.30 Mn |
| Sep 30, 2025 | -299.10 Mn |
| Jun 30, 2025 | -290.30 Mn |
| Mar 31, 2025 | -282.90 Mn |
| Dec 31, 2024 | -282.12 Mn |
| Sep 30, 2024 | -268.60 Mn |
| Jun 30, 2024 | -260.60 Mn |
| Mar 31, 2024 | 257.91 Mn |
| Dec 31, 2023 | 255.91 Mn |
| Sep 30, 2023 | 253.85 Mn |
| Jun 30, 2023 | 251.48 Mn |
| Mar 31, 2023 | -205.00 Mn |
| Dec 31, 2022 | 196.25 Mn |
| Sep 30, 2022 | -192.20 Mn |
| Jun 30, 2022 | -181.20 Mn |
| Mar 31, 2022 | 178.43 Mn |
| Dec 31, 2021 | 175.66 Mn |
| Sep 30, 2021 | 173.20 Mn |
| Jun 30, 2021 | -196.70 Mn |